Fagron NV (OTCMKTS:ARSUF – Get Free Report) was the target of a significant increase in short interest in June. As of June 15th, there was short interest totaling 8,558 shares, an increase of 358.1% from the May 31st total of 1,868 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.
Fagron Stock Performance
OTCMKTS ARSUF opened at $26.53 on Friday. Fagron has a 52 week low of $26.00 and a 52 week high of $27.00. The business has a 50 day moving average price of $26.53 and a 200-day moving average price of $26.05.
Fagron Company Profile
Fagron (OTCMKTS:ARSUF) is a global pharmaceutical compounding company that supplies raw materials, equipment and services to compounding pharmacies, hospitals and healthcare practitioners. Its portfolio encompasses a range of pharmaceutical ingredients, dosage forms and specialized compounding solutions designed to meet patient-specific needs. The company supports the preparation of customized medications in areas such as dermatology, pain management, hormone replacement therapy and veterinary medicine, providing both sterile and non-sterile compounding products.
Headquartered in Rotterdam, the Netherlands, Fagron operates in more than 55 countries across Europe, the Americas, Asia-Pacific and the Middle East & Africa.
Featured Stories
- Five stocks we like better than Fagron
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Fagron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fagron and related companies with MarketBeat.com's FREE daily email newsletter.
